Ironwood Pharmaceuticals Reports Third Quarter 2021 Results and Provides Corporate Development Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. ACN
4. IBM
5. SPCX
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Ironwood Pharmaceuticals Reports Third Quarter 2021 Results and Provides Corporate Development Update

Ironwood Pharma (IRWD) Tops Q3 EPS by 2c

November 4, 2021 7:16 AM EDT

Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.33, $0.02 better than the analyst estimate of $0.31. Revenue for the quarter came in at $103.8 million versus the consensus estimate of $105.4 million.

GUIDANCE:

Ironwood Pharma sees FY2021 revenue of $390-410 million, versus the consensus of... More